GEA Procomac receives FDA letter of non-objection for aseptic filling technology

April 10, 2008 — /HUDSON, WI/ — GEA Procomac, a GEA Group company specialized in aseptic filling technology for PET containers, has received a letter of non-objection from the United States Food & Drug Administration for aseptic filling systems for low acid shelf-stable products.

The non-objection letter was granted after FDA review of a master file submission based on the company’s aseptic line installation at Aseptic Solutions Inc., a company based in Corona, CA. The National Food Laboratory served as Procomac’s process authority for the master filing.

Procomac FDA-compliant aseptic filling technology for PET uses peracetic acid in liquid form to sterilize containers. Full recovery of sterilizing solution and rinsing water is built in the system to reduce consumption of chemicals.

Procomac has pioneered a number of aseptic technologies in the past ten years, including the use of a microbiological isolator technology instead of the traditional cleanroom environment for aseptic filling lines.

Procomac currently has installed 86 aseptic filling lines; 30 of them are capable of running low acid products, and 6 of these lines have been built to FDA standards in the United States.

GEA Niro Inc. is a full-service engineering company offering systems and solutions for liquid and powder processing. It is responsible for sales, service, and local project support and procurement for GEA Procomac in the United States.



Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.